Nancy Navarro-Gonzalez, MD
Psychiatry · Miami, FLNPI 1932125275
Payments from drug & device makers
Across 743 payments — averaging $3490.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$1.2M
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$962K
- Boehringer Ingelheim$394K
- Teva Pharmaceuticals USA, Inc.$52K
- Boehringer Ingelheim RCV GmbH & Co KG$13K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$8K
- plus $4K from 18 others
Across 7 payments — averaging $169.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 21 | $1,161,706 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 342 | $961,690 |
| Boehringer Ingelheim | 9 | $394,210 |
| Teva Pharmaceuticals USA, Inc. | 124 | $51,827 |
| Boehringer Ingelheim RCV GmbH & Co KG | 21 | $12,512 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $7,700 |
| AbbVie(2 entities) | 93 | $1,265 |
| Sunovion Pharmaceuticals Inc. | 47 | $763 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $412 |
| Otsuka America Pharmaceutical, Inc. | 22 | $362 |
| Alkermes, Inc. | 9 | $181 |
| Lundbeck LLC | 11 | $181 |
| Boehringer Ingelheim International GmbH | 1 | $167 |
| Genentech USA, Inc. | 2 | $107 |
| Neuronetics, Inc. | 3 | $86 |
| Shire North American Group Inc | 4 | $79 |
| Bausch Health US, LLC | 3 | $52 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| Idorsia Pharmaceuticals US Inc | 2 | $33 |
| Lilly USA, LLC | 1 | $21 |
| Abbott | 1 | $21 |
| Viiv Healthcare Company | 1 | $20 |
| Johnson & Johnson | 1 | $16 |
| Eisai Inc. | 1 | $16 |
How this compares
$2,593,476 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Miami
- Silvia Silva-DulucMiami$11.7M
- Patricia JunqueraMiami$10.8M
- Evelio SosaMiami$6.9M
- Mario CuervoMiami$6.7M
- Emelina ArochaMiami$4.9M
- Maria RodilMiami$4.5M
- Marc AgroninMiami$4M
- Francisco RicartMiami$2.6M
- Durim BozhdarajMiami$2.4M
- Carlos DangerMiami$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.